Diastolic and systolic heart failure: Different stages or distinct phenotypes of the heart failure syndrome?

Current Heart Failure Reports

Volumn 6, Issue 4, 2009, Pages 281-286

  Paulus, Walter J ^a   Bronzwaer, Jean G F ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORTALIDONE; CONNECTIN; CONNECTIN N2B; CONNECTIN N2BA; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; LISINOPRIL; PLACEBO; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; FUNCTIONAL ANATOMY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SYSTOLIC HEART FAILURE;

HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; MORBIDITY; PHENOTYPE; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT; WORLD HEALTH;

EID: 72449206289     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-009-0038-0     Document Type: Review

References (35)

1. T.E. Owan D.O. Hodge R.M. Herges, et al. 2006 Trends in prevalence and outcome of heart failure with preserved ejection fraction N Eng J Med 355 251 259 10.1056/NEJMoa052256 1:CAS:528:DC%2BD28XntVWktr0%3D (Pubitemid 44079340)
2. G.W. De Keulenaer D.L. Brutsaert 2009 The heart failure spectrum. Time for a phenotype-oriented approach Circulation 119 3044 3046 10.1161/ CIRCULATIONAHA.109.870006 19506105
3. J.E. Sanderson 2007 Heart failure with a normal ejection fraction Heart 93 155 158 10.1136/hrt.2005.074187 1:STN:280:DC%2BD2s%2FjtVWitw%3D%3D 16387829 (Pubitemid 46180287)
4. J. McMurray M.A. Pfeffer 2002 New therapeutic options in congestive heart failure. Part II Circulation 105 2223 2228 10.1161/01.CIR.0000014771.38666.22 11994259 (Pubitemid 34517169)
5. W.J. Paulus C. Tschöpe J.E. Sanderson, et al. 2007 How to diagnose diastolic heart failure? A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction (HFNEF) by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2539 2550 10.1093/eurheartj/ehm037 17428822 (Pubitemid 47614269)
6. J.G. Cleland A. Cohen-Solal J.C. Aguilar, et al. 2002 Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey Lancet 360 1631 1639 10.1016/S0140-6736(02)11601-1 1:STN:280:DC%2BD38nps12gsA%3D%3D 12457785 (Pubitemid 35379734)
7. S.D. Solomon N. Anavekar H. Skali, et al. 2005 Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients Circulation 112 3738 3744 10.1161/CIRCULATIONAHA.105.561423 16330684 (Pubitemid 43739514)
8. D.S. Lee P. Gona R.S. Vasan, et al. 2009 Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute Circulation 119 3070 3077 10.1161/CIRCULATIONAHA.108.815944 19506115
9. J. Wang S.F. Nagueh 2009 Current perspectives on cardiac function in patients with diastolic heart failure Circulation 119 1146 1157 10.1161/CIRCULATIONAHA.108.822676 19255354
10. M.H. Drazner 2005 The transition from hypertrophy to failure. How certain are we? Circulation 112 936 938 10.1161/CIRCULATIONAHA.105.558734 16103249 (Pubitemid 41170258)
11. K.M. Harris P. Spirito M.S. Maron, et al. 2006 Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 216 225 10.1161/CIRCULATIONAHA. 105.583500 16831987 (Pubitemid 44297115)
12. C.S. Lam V.L. Roger R.J. Rodeheffer, et al. 2007 Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County Circulation 115 1982 1990 10.1161/CIRCULATIONAHA.106.659763 17404159 (Pubitemid 46625948)
13. W. Lieb V. Xanthakis L.M. Sullivan, et al. 2009 Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the Framingham offspring study Circulation 119 3085 3092 10.1161/CIRCULATIONAHA.108.824243 19506113
14. M. Klapholz M. Maurer A.M. Lowe, et al. 2004 Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York heart failure registry J Am Coll Cardiol 43 1432 1438 10.1016/j.jacc.2003.11.040 15093880 (Pubitemid 38496351)
15. H. Bahrami D.A. Bluemke R. Kronmal, et al. 2008 Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 51 1775 1783 10.1016/j.jacc.2007.12.048 1:CAS:528:DC%2BD1cXlsFOjtb0%3D 18452784 (Pubitemid 351608497)
16. M.R. Zile W.H. Gaasch J.D. Carroll, et al. 2001 Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 104 779 782 10.1161/hc3201.094226 1:STN:280:DC%2BD3Mvls12hug%3D%3D 11502702
17. L. Van Heerebeek A. Borbely H.W. Niessen, et al. 2006 Myocardial structure and function differ in systolic and diastolic heart failure Circulation 113 1966 1973 10.1161/CIRCULATIONAHA.105.587519 16618817 (Pubitemid 43754199)
18. L. Van Heerebeek N. Hamdani L. Handoko, et al. 2008 Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation endproducts and myocyte resting tension Circulation 117 43 51 10.1161/CIRCULATIONAHA.107.728550 18071071 (Pubitemid 350291180)
19. S.H. Ahmed L.L. Clark W.R. Pennington, et al. 2006 Matrix metalloproteinases/tissue inhibitors of metalloproteinases. Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease Circulation 113 2089 2096 10.1161/CIRCULATIONAHA.105.573865 1:CAS:528: DC%2BD28XjslKiur8%3D 16636176 (Pubitemid 43755159)
20. F.G. Spinale M.L. Coker L.J. Heung, et al. 2000 A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure Circulation 102 1944 1949 1:CAS:528:DC%2BD3cXnvV2qtb4%3D 11034943
21. V. Polyakova S. Hein S. Kostin, et al. 2004 Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression J Am Coll Cardiol 44 1609 1618 10.1016/j.jacc.2004.07.023 1:CAS:528:DC%2BD2cXos12isr4%3D 15489093 (Pubitemid 39369793)
22. A. Borbély J. van der Velden Z. Papp, et al. 2005 Cardiomyocyte stiffness in diastolic heart failure Circulation 111 774 781 10.1161/01.CIR.0000155257.33485.6D 15699264 (Pubitemid 40250638)
23. A. Borbély L. van Heerebeek W.J. Paulus 2009 Transcriptional and posttranslational modifications of titin: implications for diastole Circ Res 104 12 14 10.1161/CIRCRESAHA.108.191130 19118283
24. I. Makarenko C.A. Opitz M.C. Leake, et al. 2004 Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts Circ Res 95 708 716 10.1161/01.RES.0000143901.37063.2f 1:CAS:528:DC%2BD2cXnvVekurs%3D 15345656 (Pubitemid 39331931)
25. S.F. Nagueh G. Shah Y. Wu, et al. 2004 Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy Circulation 110 155 162 10.1161/01.CIR.0000135591.37759.AF 1:CAS:528:DC%2BD2cXltlOrt7Y%3D 15238456 (Pubitemid 38924583)
26. M. Krüger S. Kötter A. Grützner, et al. 2009 Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs Circ Res 104 87 94 10.1161/CIRCRESAHA.108.184408 19023132
27. A. Borbély I. Falcao-Pires L. van Heerebeek, et al. 2009 Hypophosphorylation of the stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium Circ Res 104 780 786 10.1161/CIRCRESAHA.108. 193326 19179657
28. M.M. Anderson J.R. Requena J.R. Crowley, et al. 1999 The myeloperoxidase system of human phagocytes generates N-epsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation J Clin Invest 104 103 113 10.1172/JCI3042 1:CAS:528: DyaK1MXktlOgsbw%3D 10393704
29. C.H. Yeh L. Sturgis J. Haidacher, et al. 2001 Requirement for p38 and p44/p42 mitogen activated protein kinases in RAGEmediated nuclear factor-kB transcriptional activation and cytokine secretion Diabetes 50 1495 1504 10.2337/diabetes.50.6.1495 1:CAS:528:DC%2BD3MXkvFSgt78%3D 11375353
30. B.R. Davis J.B. Kostis L.M. Simpson, et al. 2008 Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Circulation 118 2259 2267 10.1161/CIRCULATIONAHA.107.762229 1:CAS:528:DC%2BD1cXhtlyks7fN 19001024
31. B.M. Massie P.E. Carson J.J. McMurray, et al. 2008 Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2456 2467 10.1056/NEJMoa0805450 1:CAS:528:DC%2BD1cXhsVCrurjE 19001508
32. C.B. Granger J.J. McMurray S. Yusuf, et al. 2003 Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensinconverting-enzyme inhibitors: the CHARM-Alternative trial Lancet 362 772 776 10.1016/S0140-6736(03)14284-5 1:CAS:528:DC%2BD3sXntVGktLs%3D 13678870 (Pubitemid 37093917)
33. A.F. Hernandez B.G. Hammill C.M. O'Connor, et al. 2009 Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) registry J Am Coll Cardiol 53 184 192 10.1016/j.jacc.2008. 09.031 1:CAS:528:DC%2BD1MXjvFahtQ%3D%3D 19130987
34. H. Fukata D.C. Sane S. Brucks W.C. Little 2005 Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report Circulation 112 357 363 10.1161/CIRCULATIONAHA.104.519876 (Pubitemid 41022076)
35. J. Kjekshus E. Apetrei V. Barrios, et al. 2007 Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2248 2261 10.1056/NEJMoa0706201 1:CAS:528:DC%2BD2sXhsVSlsLvI 17984166 (Pubitemid 350190755)